Objectives: Enterococci may increase morbidity and mortality in elderly patients with intra-abdominal infections (IAIs) hospitalized in the intensive care unit (ICU).
Introduction
Severe intra-abdominal infection is one of the major causes of infection in the intensive care unit (ICU). 1 Despite improvements in ICU management, the mortality of this disease remains high. This is probably due to an increase in the number of older patients with other underlying diseases; given that overall improvements in healthcare have increased life expectancy, elderly patients survive longer and this causes the ICU admission rate to rise accordingly. 2 Furthermore, age is always associated with a poorer prognosis in severe intra-abdominal infection associated with organ failure. 3 -5 Intra-abdominal infection is a model example of polymicrobial infection with a high inoculum of bacteria, including Enterobacteriaceae, anaerobes, streptococci and enterococci. It has been shown experimentally that Escherichia coli is closely involved in septic shock and mortality. 6 In contrast, enterococci and anaerobes are more involved in secondary intra-abdominal abscesses. 6 However, the pathogenicity of enterococci in clinical intra-abdominal infection is still subject to debate. All the studies published to date have shown at least an increase in morbidity 7 -11 and, in some cases, an increase in mortality when enterococci are isolated from the peritoneal fluid. 12, 13 Enterococci have been previously linked with infections in the # The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2011; 66: 2379 -2385 doi:10.1093/jac/dkr308 Advance Access publication 25 July 2011 elderly, especially in skin and soft tissue infections, endocarditis and urinary tract infections. 14 -16 However, no data are available in the literature concerning intra-abdominal infections, which represent the second most common cause of severe sepsis and septic shock in the ICU. 17 This is of importance because the systematic coverage of enterococci in severe intra-abdominal infections may require a change in our empirical antimicrobial therapy.
The aim of this study was to evaluate the impact of isolation of enterococci on outcomes of severe intra-abdominal infections in elderly patients hospitalized in the ICU.
Methods

Patients and definitions
After approval of the study by the local investigational review board (CEERNI Amiens), we performed a retrospective analysis of a prospective cohort database of elderly patients hospitalized in our ICU for severe intra-abdominal infection between 1997 and 2007. Elderly patients were defined as being ≥75 years old. Both nosocomial infections (whether postoperative or not) and community-acquired infections were included. Primary peritonitis cases were not considered and tertiary infections were not included. The patients had been admitted to the ICU for major co-morbidities and/or organ failure. The only exclusion criterion was the lack of a peroperative sample of peritoneal fluid. Sampling of peritoneal fluid was systematically performed by the surgeons in the operating room at the beginning of the procedure. The procedure in the emergency operating room was to collect a first sample for direct examination plus culture, and a second sample was inoculated in an anaerobic blood culture bottle (Bactec w ; Becton Dickinson, USA). The samples were routed to the microbiology laboratory within 1 h (with 24 h coverage throughout the year). At least three blood cultures for bacteria [both aerobic and anaerobic bottles (Bactec w ) and one specific for yeast (Bactec mycosis w ; Becton Dickinson, USA)] were performed during the first 24 h. Enterobacteriaceae were classified according to their wild-type phenotype of resistance to b-lactam antibiotics: Class 1 corresponded to no wild-type resistance to b-lactam antibiotics, Class 2 to a chromosomal penicillinase and Class 3 to a natural inducible cephalosporinase. 18 The antibiotic use protocols did not change in the unit during the study period. For severe community-acquired infections, a combination of piperacillin/tazobactam with gentamicin was recommended. For severe postoperative infections, a combination of piperacillin/tazobactam or imipenem plus amikacin and vancomycin was recommended.
Data collection
The study data were collected from the ICU patients' charts. All the patients with a diagnosis of intra-abdominal infection during the study period were found using the International Classification of Diseases (ICD-10) in the database of the unit. A fellow was in charge of the chart review. All patients included were reviewed once a week by senior physicians to ensure completion of the case report form. No missing data were allowed, and if any data were missing the fellow was instructed to look in the archives of the laboratory, the surgical department and so on. Demographic characteristics such as age, gender and weight were recorded. Any underlying diseases and/or longterm treatments were noted. The McCabe score, 19 Charlson score 20 and Chronic Disease Score 21 were calculated. Severity and organ failure scores [Simplified Acute Physiologic Score 2 (SAPS2) 22 and Sepsis-related Organ Failure Assessment (SOFA), 23 respectively] were calculated on the first day after admission to the ICU. The cause of the intra-abdominal infection and its type (postoperative or community acquired) was noted. Blood and peritoneal fluid culture results were analysed and the presence or absence of multidrug-resistant pathogens was noted. Microbial identification was performed according to the recommendations of the French Society of Microbiology and susceptibility testing to the Committee on Antibiogramme of the French Society of Microbiology. A usually susceptible pathogen was considered to be multiresistant if it presented resistance to at least three clinically useful antibiotics of different classes. The appropriateness of empirical antimicrobial therapy was assessed in the light of available susceptibility testing results. To be considered appropriate, empirical antimicrobial therapy had to have covered all bacteria isolated in the peritoneal fluid. Yeasts were not considered for appropriateness in this study. The use of vasopressors and/or the need for an extrarenal replacement therapy were noted. Lastly, length of stay in the ICU, the duration of mechanical ventilation and the need for reoperation were recorded. Overall mortality in the ICU was assessed.
Statistical analysis
The group of patients with a positive peritoneal fluid culture for Enterococcus (hereafter the 'E+ group') was compared with the group of patients lacking Enterococcus (hereafter the 'E2 group'). Data are presented as the mean+standard deviation or as numbers and percentages. Continuous parameters were compared with the bilateral t-test. Categorical data were compared with the x 2 test with Yates' correction or, when necessary, Fisher's exact test. Two multivariate stepwise logistic regression models (backward Wald model) were built in order to identify any independent factors for Enterococcus isolation and for ICU mortality in elderly patients with severe intra-abdominal infections. Adjusted odds ratios (AORs) and their 95% confidence intervals (CIs) are reported. The number of variables included in the model corresponded to the recommended ratio of 10/1. 24 The probability of entering the model was set to 0.05 and that of removal to 0.1. The constant (intercept) was included in the model only if significant. 24 The Hosmer-Lemeshow test was performed to assess the goodness of fit of the model. 24 The statistical significance of individual regression coefficients was tested using the Wald x 2 test. 24 The predicted probabilities of the model were validated with the c-statistic, corresponding to the area under the curve of the model. 24 The threshold for statistical significance was set to P≤ 0.05. The statistical analysis was performed with PASW Statistics 18 software (IBM, Chicago, USA).
Results
A total of 637 patients with severe intra-abdominal infection were hospitalized in the ICU during the study period. One hundred and eighty patients ≥75 years old were screened and 20 were excluded because of lack of a peritoneal fluid sample (11.1% of intra-abdominal infection patients). The overall ICU mortality rate was 47.5% (76 out of 160). The main characteristics of the two groups of elderly patients are presented in Table 1 . The E+ group presented higher SAPS2 and SOFA scores than the E2 group (P,0.001 for both scores). Although all patients typically had several other underlying diseases and long-term treatments, the E+ group presented a significantly higher prevalence of chronic heart failure than the E2 group (P ¼ 0.02). Eight patients in each group had been receiving antimicrobial therapy for 5.0+3.5 days at the time of surgery. No differences in empirical antimicrobial therapy were observed between the E+ and E2 groups (P ¼ 0.59) with respect to monotherapy [19 Table 2 . The postoperative infection rate was higher Dupont et al. in the E+ group than in the E2 group (P ¼ 0.01). No difference in the initial localization of peritonitis was observed. We found a significant intergroup difference in terms of the proportions of bacteria isolated from the peritoneal fluid, as summarized in Table 3 (P,0.0001). In all, 357 identifications were made. The E+ group had a lower proportion of anaerobes and yeast infections but the same proportion of Gram-negative bacilli. The number of distinct bacteria per patient was higher in the E+ group than in the E2 group (2.8+1.1 and 1.8+0.9, respectively; P ¼ 0.001) but yeasts were isolated less frequently [7 (9.7%) in the E+ group versus 18 (20.5%) in the E2 group, P ¼ 0.06]. However, the proportion of multidrug-resistant strains was higher in the E+ group than in the E2 group [18 (25.0%) and 11 (12.5%), respectively; P ¼ 0.04]. There was no difference between the E+ and E2 groups in terms of the bacteraemia rate [12 (16.7% ) and 8 (9.1%), respectively; P ¼0.11] or the Table 5 . The E+ group was more likely to have received inappropriate empirical antimicrobial therapy (P ¼ 0.04) despite a shorter duration of antimicrobial therapy (P ¼ 0.001), longer mechanical ventilation (P¼ 0.02) and longer vasopressor use (P ¼0.0001). There were trends towards more frequent reoperation (P ¼ 0.1) and a greater number of distinct operations (P ¼0.06) in the E+ group. Lastly, the ICU mortality was higher in the E+ group than in the E2 group (P ¼0.05). Five parameters were independently associated with higher ICU mortality of severely ill, elderly patients with an intra-abdominal infection (Table 6) 
Discussion
Our results demonstrated that enterococci were frequently involved in severe intra-abdominal infections in elderly patients with organ failure in the ICU, regardless of the aetiology. Furthermore, isolation of enterococci was associated with a worse outcome and was an independent risk factor for ICU mortality in this population.
For many years, it has been considered that enterococci have low pathogenicity in human intra-abdominal infections. Nevertheless, studies in animal models of intra-abdominal infection have shown: (i) a marked pro-inflammatory effect of enterococci; 25 (ii) responses that vary according to the presence of virulence factors; 26 and (iii) a probable inverse relationship between virulence and resistance. 27 Furthermore, enterococcal virulence factors are known to be independently associated with the ICU mortality of severely ill patients. 28 Our observed Enterococcus isolation rate of 45% in elderly patients with severe intra-abdominal infections is higher than the values found in the literature, which range from 5% to 26% for community-acquired infections 9,10,12,29 -36 and from 20% to 28% for postoperative infections. 30,34,37 -39 Of course, the Enterococcus isolation rate was always higher for postoperative infections than for community-acquired infections, 7, 8 as we also found. Studies of microbiology reports in tertiary peritonitis alone have revealed rates of up to 40% of enterococci. 40, 41 The nature of the relationship between the Enterococcus isolation rate and patient age is unclear and explanatory hypotheses have never been published in the literature.
In the present study, the E+ group was more severely ill (according to SOFA and SAPS2 scores). This observation is in 39 who found a significant relationship between enterococcus isolation and the development of septic shock in ICU patients with community-acquired intra-abdominal infections. This has also been reported for patients infected with enterococci, with highest APACHE II scores in two Spanish studies, 8, 10 and a post hoc analysis of a prospective, randomized trial. 7 We did not find any intergroup differences in terms of the Charlson score, Chronic Disease Score or McCabe score, although this would have been unlikely in a specific population with mean age of 82 years and a high co-morbidity rate. However, higher Charlson scores and McCabe scores have been reported in younger patients with intra-abdominal infection in whom enterococci were isolated. 8 The frequency of isolation of the various Enterococcus species in elderly patients differed from the value we have previously reported in a younger population. 28 In particular, the proportion of E. faecalis was lower (210%) and that of E. faecium was higher (+15%) in our present study relative to our previous work in younger subjects. 28 One explanation could be a higher rate of postoperative infections in this study because of a clear relationship between increased E. faecium rate and nosocomial infections. However, the two studies featured the same rate of amoxicillin resistance in E. faecium (50%). 28 This is important because the rate of inappropriate antimicrobial therapy was higher in the E+ group of elderly patients (mainly due to b-lactam-resistant strains of E. faecium). Only two strains of vancomycin-resistant enterococci (VRE) were isolated in this study. However, this is unsurprising in view of the very low incidence of VRE in France.
The present study revealed a strong, independent association between mortality and the presence of enterococci in the peritoneal fluid in elderly, severely ill patients in the ICU. In a French, prospective, multicentre cohort study of 331 patients, the presence of enterococci was associated with mortality in a univariate analysis (odds ratio 2.86, 95% CI 1.44-5.68) but not in a multivariate analysis. 12 When enterococci were not covered by the initial antimicrobial treatment, the enterococcal postoperative infection rate was higher and was associated with significantly greater mortality. 10 Only one study has reported an independent association between mortality and enterococci in intra-abdominal infections; this association was found in a severely ill population with a mortality rate of 25%. 13 Although there are no comparable data concerning elderly, severely ill patients, it seems that the number and severity of co-morbidities, the number of organ failures and advanced age are important risk factors for greater enterococcal pathogenicity. The results of this study are of importance because it is the first to demonstrate increased mortality associated with elderly patients with severe intra-abdominal infections. This might change the point of view of physicians about the low pathogenicity of Enterococcus, especially in elderly patients.
Many studies have shown the negative impact of enterococci on morbidity. We found in the present study a longer duration of mechanical ventilation and greater vasopressor use in E+ elderly ICU patients. Mosdell et al. 42 first reported a relationship between the appropriateness of antibiotic treatment for enterococci and a 50% increase in the incidence of postoperative wound infections. Sitges-Serra et al. 10 reported a greater rate of septic complications in enterococcus-positive intra-abdominal infection patients than in controls. Interestingly, the latter authors evidenced a higher enterococcal postoperative infection rate when enterococci were not covered by the initial antimicrobial treatment. A post hoc analysis of a prospective randomized trial showed that enterococci were independently associated with treatment failure. 7 Similar findings were presented in a meta-analysis of three prospective randomized trials comparing ertapenem and piperacillin/tazobactam; 43 the presence of enterococci was associated with significantly lower cure rates and an odds ratio (95% CI) for failure of 2.3 (1.2 -4.1). Gauzit et al. 9 showed that enterococci were independently associated with a higher reoperation rate in community-acquired intra-abdominal infections. Only one prospective randomized study has sought to compare treatment and non-treatment of enterococci in intra-abdominal infections in non-severely ill patients with community-acquired infections. 44 Unfortunately, no firm conclusions could be drawn because the study was markedly underpowered and had a very low Enterococcus isolation rate (5.4%).
This study had several limitations, since it was a retrospective analysis of a prospective cohort in the ICU. However, this is the first study to have analysed such a large number of elderly patients with organ failure in the ICU. The use of a computer database in the ICU limited the number of missing or aberrant data. Another limitation of the study may be the single-centre analysis. The number of patients with ongoing antimicrobial therapy was low in this study, which should reduce false negative results of the peritoneal fluid culture. Of course, the results of this study can be interpreted only in patients with a positive culture performed. The number of patients excluded (n¼ 20) due to a lack of culture was low in this study. However, these 11.1% of patients might have influenced the results. Long-term (post-ICU) mortality and quality of life were not assessed, due to the study's retrospective design.
In conclusion, the presence of enterococci in the peritoneal fluid of elderly patients with intra-abdominal infection in the ICU is associated with greater morbidity and is an independent risk factor for greater mortality. However, Enterococcus may represent a marker of morbidity and severity in elderly patients. Regardless of the aetiology of intra-abdominal infections (community-acquired or postoperative), our results pose the question of coverage of enterococci in empirical antibiotic treatment. Of course, only a prospective randomized trial will be able to provide a definitive answer to this question.
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